A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This phase Ib/II study is designed to evaluate the safety, tolerability, pharmacokinetics, and efficacy of injectable BL-M07D1 in patients with HER2-mutated, locally advanced or metastatic non-small cell lung cancer.
Epistemonikos ID: d805bc4772852ced053773b81b0a1ce262c4628e
First added on: May 15, 2024